The United States District Court for the Northern District of Texas, Dallas Division, has entered a Final Judgment and Permanent Injunction against Boston Mountain Laboratories, Inc., which bans Boston Mountain Laboratories from manufacturing or selling BML Glyconutrient Formula, Glyco-8, Glycoessentials, Glyco-Essence, Glyconutrients, MG-3, and MG-3c for the duration of Mannatech’s U.S. Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220.
The courts have recognized that Mannatech is the rightful owner of the patented technology concerning “Compositions of Plant Technology as Dietary Supplements.” As part of the final judgment in this case, Boston Mountain Laboratories, plus its officers, agents, employees, and any persons acting in concert or participation with the company, are prohibited from making, using, selling, or otherwise distributing within the United States any of the accused products or any colorable imitations thereof.“Mannatech has demonstrated that it will fight to protect its intellectual property. The Court’s decision is further notice to all interested parties that we will do what is necessary to support our products and our independent sales Associates in the field,” said Keith Clark, senior vice president and general counsel of Mannatech.
Mannatech has vigorously pursued patent infringement cases against companies to stop their manufacture and sale of infringing products. The company’s first victory came last year, when Mannatech won on all patent and trademark infringement claims brought against Glycobiotics International, Inc. As part of the final judgment in that case, Glycobiotics was ordered to stop production of its infringing product Glycomannan and deliver any existing product to Mannatech for destruction.
